FOXP3 and neoplasm: Using drugs that reduce expression of FOXP3, such as histone acetyltransferase inhibitors or interfering RNA treatments, could reduce the suppressive activity of affected Tregs to alleviate reduced anti-tumor immunity as well as reduce the number of tumors infiltrating Tregs [89].